Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Tema Oncology ETF (NQ: CANC ) 28.05 UNCHANGED Streaming Delayed Price Updated: 4:15 PM EDT, Aug 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 28.05 Bid (Size) 11.28 (1) Ask (Size) 44.59 (1) Prev. Close 28.05 Today's Range 28.05 - 28.05 52wk Range 21.26 - 30.00 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market April 25, 2024 The radiopharmaceuticals space could be worth up to $25 billion, according to one estimate. Via Investor's Business Daily Healthcare ETFs For The Weight-Loss Drug Boom And Beyond April 08, 2024 Two dominant investing themes over the past year have been AI and weight-loss drugs. Via Talk Markets Topics Artificial Intelligence ETFs Exposures Artificial Intelligence Performance YTD +5.41% +5.41% 1 Month -4.46% -4.46% 3 Month +1.14% +1.14% 6 Month +3.43% +3.43% 1 Year +11.87% +11.87% More News Read More Biden's Million Dollar Moonshot - $240 Million Is A Boon For Cancer Research, Will it be a Boost For Pharma Stocks Too? December 05, 2023 Via Benzinga EXCLUSIVE: Tema ETFs' Innovative Thematic Investing Approach Targets New Opportunities Beyond The Fads December 01, 2023 Via Benzinga Topics ETFs Active ETFs Appear Booming In 2023 — Tema ETFs Are Taking Them Into A New Direction November 28, 2023 Via Benzinga Topics ETFs Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF? November 21, 2023 Via Benzinga Topics ETFs Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
